American Kratom Association (AKA) will host a special press conference to address the recent FDA warning letters targeting 7-hydroxymitragynine (7-OH) products. The event will feature the AKA’s official response, expert commentary on public safety implications, and details of the industry's commitment to consumer protection. Dr. Chris McCurdy of the University of Florida, an internationally recognized expert on kratom, will be attending and available to the media.
The AKA has issued a national consumer alert on the action.
Following the press conference, media are invited to attend a highly anticipated live debate and policy presentation titled: "The 7-OH Fault Line: Can the Industry Find Common Ground?"
This critical session will feature representatives from the American Kratom Association and the Holistic Alternative Recovery Trust (HART)—an organization that supports 7-OH product access—engaging in a robust discussion on science, safety, and regulatory futures.
Visit here to register or submit a question beforehand.
Press Conference Details
- Date: Friday, July 25, 2025
- Time: 10:00 a.m. PT
- Location: Chairman Room – 2nd Floor, Renaissance Las Vegas Hotel (3400 Paradise Rd, Las Vegas, NV 89169)
"The 7-OH Fault Line" Debate Details
- Date: Friday, July 25, 2025
- Time: 3:00 p.m. PT
- Location: Room 221, Las Vegas Convention Center (3150 Paradise Rd, Las Vegas, NV 89109
Why It Matters
This is a pivotal moment for the kratom industry and public health regulation. As federal action intensifies, the future of kratom—and the distinction between mitragynine and 7-OH products—is on the line. Media will have direct access to the facts, major players, and contrasting perspectives shaping this critical debate.
Who Should Attend
Local and national press, health reporters, regulatory affairs journalists, and industry media outlets covering FDA policy, herbal supplements, consumer safety, and alternative health products.
